Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

Overview of attention for article published in CNS Drugs, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 43 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 15,059 followers.

RT @somosem: Mejora en la función cognitiva en pacientes con #esclerosismúltiple recurrente tratados con Natalizumab: un análisis retrospec…

22 Oct 2018

Reply Repost Favourite

Mejora en la función cognitiva en pacientes con #esclerosismúltiple recurrente tratados con Natalizumab: un análisis retrospectivo de 2 años https://t.co/fZHo5KjMUb https://t.co/nTk0hWVBV5

22 Oct 2018

Reply Repost Favourite

"Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis" https://t.co/3SrlAegrlj

26 Aug 2018

Reply Repost Favourite